LEAH Labs

company

About

LEAH Labs provides Car T cells for curing B-cell lymphoma cancer in dogs .

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Biotechnology,Health Care,Product Research
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

LEAH Labs provides Car T cells for curing B-cell lymphoma cancer in dogs.

Scientists at LEAH Labs use precision gene editing to reprogram T immune cells with Chimeric Antigen Receptors (CAR) in order to create CAR T cells that seek out, specifically recognize, and destroy B cell lymphoma without the off-target side effects that come with chemotherapy.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$325K
LEAH Labs has raised a total of $325K in funding over 2 rounds. Their latest funding was raised on May 10, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 10, 2022 Grant $100K 1 Detail
May 8, 2020 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
2
LEAH Labs is funded by 2 investors. National Science Foundation and Regenerative Medicine Minnesota are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Regenerative Medicine Minnesota Grant